期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
The Aryl Hydrocarbon Receptor: A Target for Breast Cancer Therapy 被引量:1
1
作者 Joann B. Powell Gennifer D. Goode Sakina E. Eltom 《Journal of Cancer Therapy》 2013年第7期1177-1186,共10页
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that regulates a battery of genes in response to exposure to a broad class of environmental poly aromatic hydrocarbons (PAH). AhR is histo... The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that regulates a battery of genes in response to exposure to a broad class of environmental poly aromatic hydrocarbons (PAH). AhR is historically characterized for its role in mediating the toxicity and adaptive responses to these chemicals, however mounting evidence has established a role for it in ligand-independent physiological processes and pathological conditions, including cancer. The AhR is overexpressed and constitutively activated in advanced breast cancer cases and was shown to drive the progression of breast cancer. In this article we will review the current state of knowledge on the possible role of AhR in breast cancer and how it will be exploited in targeting AhR for breast cancer therapy. 展开更多
关键词 ARYL HYDROCARBON Receptor THERAPEUTIC Targeting BREAST Cancer PROGRESSION CHEMOSENSITIZATION
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部